PUMA BIOTECHNOLOGY INC's ticker is PBYI and the CUSIP is 74587V107. A total of 136 filers reported holding PUMA BIOTECHNOLOGY INC in Q4 2019. The put-call ratio across all filers is 1.14 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $12,573,000 | -11.7% | 1,246,121 | -8.7% | 2.28% | +64.4% |
| Q2 2020 | $14,241,000 | +110.9% | 1,365,376 | +70.7% | 1.38% | +46.0% |
| Q1 2020 | $6,752,000 | +120.9% | 800,000 | +129.0% | 0.95% | +159.7% |
| Q4 2019 | $3,057,000 | -18.7% | 349,400 | 0.0% | 0.36% | -43.2% |
| Q3 2019 | $3,761,000 | -15.3% | 349,400 | 0.0% | 0.64% | +7.2% |
| Q2 2019 | $4,441,000 | -67.2% | 349,400 | 0.0% | 0.60% | -76.0% |
| Q1 2019 | $13,553,000 | +169.2% | 349,400 | +41.2% | 2.50% | +116.2% |
| Q4 2018 | $5,035,000 | – | 247,400 | – | 1.16% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Camber Capital Management LP | 2,400,000 | $25,032,000 | 1.43% |
| TANG CAPITAL MANAGEMENT LLC | 1,365,376 | $14,241,000 | 1.38% |
| Palo Alto Investors LP | 1,343,897 | $14,017,000 | 0.84% |
| Sofinnova Investments, Inc. | 1,197,630 | $12,491,000 | 0.79% |
| Gyon Technologies Capital Management, LP | 29,745 | $310,000 | 0.75% |
| RICE HALL JAMES & ASSOCIATES, LLC | 455,567 | $4,752,000 | 0.20% |
| GLOBEFLEX CAPITAL L P | 63,226 | $659,000 | 0.17% |
| PDT Partners, LLC | 188,538 | $1,966,000 | 0.13% |
| CADENCE CAPITAL MANAGEMENT LLC | 71,179 | $742,000 | 0.11% |
| FRED ALGER MANAGEMENT, LLC | 2,474,029 | $25,804,000 | 0.08% |